SynCore Biotechnology2019-03-13T12:09:54+08:00

PIPELINE

Research & Development

SB01,SB02

SB05 PC

SB05 TNBC

SB03

SB04

SynCore Biotechnology

Professional, Innovation, and Respect of life

We are a global, new drug developing biopharmaceutical company provide only evidence-based medicine.
Established in 2008, SynCore was cofounded by Sinphar Group and National Health Research Institute (NHRI) Taiwan. We focus on creating values of new drug by R&D management and integration of technology resources. SynCore’s pipeline concentrates on oncology, ophthalmology, and dermatology fields, continuously dedicates in helping patients worldwide.

About Us

Latest News

More

Recent Events

More